Drug more effective on pain than gabapentin, minus side effects - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 15, 2023 at 3:00 PM in health No comments 7
Hepatitis B drug developers chart slow progress forward, just like hep C before it - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 15, 2023 at 2:05 PM in health No comments 56
Verve shows base editing works in humans in first clinical data—and is punished by investors - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 14, 2023 at 1:43 PM in business No comments 38
AstraZeneca's long-term GLP-1 play is weight management, not obesity, CEO says - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 11, 2023 at 5:08 PM in business No comments 11
Drug has power of nature's strongest antibiotic, but less toxic - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 10, 2023 at 3:30 PM in health No comments 61
Siemens Healthineers reports 300 layoffs amid rumors of a possible diagnostics unit sell-off - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 4, 2023 at 3:50 PM in business No comments 49
After Sarepta miss, Pfizer's DMD gene therapy is 'main game in town,' CSO says - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on November 1, 2023 at 6:28 PM in business No comments 13
CRISPR-Vertex gene editing 1st gets narrow review by FDA panel - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 28, 2023 at 3:20 PM in business No comments 44
Sanofi reports setbacks to Denali, Kymab and Principia assets, delivering mix of misses and halts - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 28, 2023 at 10:25 AM in business No comments 14
Merck pays $4B for Daiichi ADCs in bet on post-Keytruda future - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 21, 2023 at 8:30 AM in business No comments 1
Beam lays off about 100 employees, deprioritizes CAR-T programs to push runway into 2026Beam lays off 20% of staff and culls CAR-T work to save cash - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 20, 2023 at 3:00 PM in business No comments 51
'Harvest time' arrives for Alzheimer's thanks to new treatments - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 17, 2023 at 10:00 AM in health No comments 57
Roche's BTK inhibitor may have reached 'holy grail' of brain penetration in phase 2 MS trialRoche's BTK inhibitor may have reached 'holy grail' of brain penetration in phase 2 MS trial - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 14, 2023 at 1:30 PM in business No comments 26
Akero's NASH miss drags a few peers down, spurring deja vu in long-challenging indicationAkero's NASH miss drags a few peers down, spurring deja vu in long-challenging indication - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 12, 2023 at 2:50 PM in business No comments 63
Best Buy to begin selling CGMs, starting with Dexcom G7 sensorBest Buy to begin selling CGMs, starting with Dexcom G7 sensor - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 10, 2023 at 2:53 PM in business No comments 43
Still 'unsatisfied’ with Philips' handling of CPAP recall, FDA calls for additional safety testingStill 'unsatisfied' with Philips' handling of CPAP recall, FDA calls for additional safety testing - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 7, 2023 at 2:36 PM in business No comments 7
AbbVie and Calico immunotherapy boosts PD-1 response and tackles T cell exhaustion in mice - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 6, 2023 at 3:19 PM in health No comments 20
FDA hopes to spur stimulant use disorder drug development - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 5, 2023 at 3:00 PM in health No comments 35
Lilly enters radiopharmaceuticals with $1.4B Point acquisition - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 4, 2023 at 1:43 PM in business No comments 16
Novartis' iptacopan has 'faultless' performance in phase 3 - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on October 3, 2023 at 3:09 PM in business No comments 45
BrainStorm's ALS cell therapy resoundingly rejected by FDA advisersBrainStorm's ALS cell therapy resoundingly rejected by FDA advisers - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on September 27, 2023 at 10:04 PM in business No comments 21
Pfizer hooks up with Ginkgo for $331M biobucks deal on unspecified targets - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on September 27, 2023 at 1:50 PM in business No comments 44
Ionis' lipid-lowering drug hits phase 3 goal, raising hopes in untapped rare disease marketIonis' lipid-lowering drug hits phase 3 goal, teeing up filings - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on September 26, 2023 at 11:00 AM in business No comments 10
The FDA spares no detail in objection to BrainStorm's NurOwn - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on September 25, 2023 at 4:00 PM in business No comments 48
Novo Nordisk pays $60M for AI-powered cardio collab with Valo - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on September 25, 2023 at 2:15 PM in business No comments 21